(PLUS, MYRX, CRWE, CAR) CRWENewsAlert.com Stock Market Report
(CRWE, MYRX, MITL) Stocks in Action by StockHotTips.com
(CRWE, LLNW, MYRX, SNBC) Stock Report from Stock-PR.com
FREE Daily Stock Alerts From Stock-PR.com
Crown Equity Holdings Inc. (CRWE)
Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers.
(CLNO, MYRX, ERII, KFY) Stock Report from Stock-PR.com
(CRWE, SNTA, MYRX, LRCX) Featured Stock by CRWEFinance.com
(CRWE, KEQU, MYRX, LOCM) Stock in Review by CRWEWallStreet.com
(THLD, OPTR, MJGCF.PK, MYRX) Stocks to Watch by PennyToBuck.com
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the Stifel Nicolaus Healthcare Conference in Boston on Friday, September 9, 2011 at 8:35AM EDT. A Live webcast of the presentation will be available under the Webcast section of the Company's Website.
(CECO, ORFG, JDAS, MYRX, CNQR) Stock Market Updates by StockHotTips.com
(ACHN, NHPR, CLNO, MYRX, ASFI) Noticeable Stock by Stock-PR.com
(RGEN, PWRM, MYRX, CRWE, FCAL) Stock Report from CRWEPicks.com
Repligen Corporation (NASDAQ:RGEN) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for RG3039, a potential treatment for Spinal Muscular Atrophy (SMA). Fast Track is a process designed to facilitate the development and expedite the review of drugs that treat serious diseases and fill an unmet medical need.